每年研究成果
每年研究成果
- 17結果
搜尋結果
-
2023
Improving the Efficiency of Medication Reconciliation in Two Taiwanese Hospitals by Using the Taiwan National Health Insurance PharmaCloud Medication System
Huang, P. P., Poon, S. Y. K., Chang, S. H., Kuo, C. W., Chien, M. W., Chen, C. C. & Chiang, S. C., 2023, 於: International Journal of General Medicine. 16, p. 211-220 10 p.研究成果: Article › 同行評審
開啟存取 -
2021
An evaluation of the healthcare costs of metastatic breast cancer: A retrospective matched cohort study
Chen, H. M., Chen, J. H., Chiang, S. C., Lin, Y. C. & Ko, Y., 29 10月 2021, 於: Medicine. 100, 43, p. e27567研究成果: Article › 同行評審
開啟存取1 引文 斯高帕斯（Scopus） -
Assessing knowledge and attitude of healthcare professionals on biosimilars: A national survey for pharmacists and physicians in taiwan
Poon, S. Y. K., Hsu, J. C., Ko, Y. & Chiang, S. C., 11月 2021, 於: Healthcare (Switzerland). 9, 11, 1600.研究成果: Article › 同行評審
開啟存取5 引文 斯高帕斯（Scopus） -
Establishing a protocol for the compatibilities of closed-system transfer devices with multiple chemotherapy drugs under simulated clinical conditions
Chiang, S. C., Shen, M., Lin, C. C. & Chang, H. P., 9月 2021, 於: PLoS ONE. 16, 9 September, e0257873.研究成果: Article › 同行評審
開啟存取1 引文 斯高帕斯（Scopus） -
2020
2020年抗癌危害性藥品居家防護指引
張黎露, 江孟冠, Chiang, S-C. & 邱詩怡, 12月 2020, 於: 腫瘤護理雜誌. 20, p. 77 - 84研究成果: Article › 同行評審
-
2020年抗癌危害性藥品給藥防護作業指引
張黎露, Chiang, S-C., 江孟冠, 陳幼貴, 周文珊, 林盈秀, 黃麗燕, 邱詩怡, 蔡靜儀, 李俊緯, 劉庭瑋 & 蕭信一, 12月 2020, 於: 腫瘤護理雜誌. 20, p. 5-76研究成果: Article › 同行評審
-
Health state utilities for metastatic breast cancer in Taiwan
Chou, T. C., Chiang, S. C. & Ko, Y., 6月 2020, 於: Breast. 51, p. 57-64 8 p.研究成果: Article › 同行評審
開啟存取6 引文 斯高帕斯（Scopus） -
2019
-
2018
第一個針對BRCA突變卵巢癌的標靶治療: Olaparib
Chiang, S-C., 12月 2018, 於: 腫瘤護理雜誌. 18, 2, p. 13-20 8 p.研究成果: Article › 同行評審
-
2017
Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis in chemotherapy-induced febrile neutropenia among breast cancer and Non-Hodgkin's lymphoma patients under Taiwan's national health insurance system
Wen, T. J., Wen, Y. W., Chien, C. R., Chiang, S. C., Hsu, W. W. Y., Shen, L. J. & Hsiao, F. Y., 1 4月 2017, 於: Journal of Evaluation in Clinical Practice. 23, 2, p. 288-293 6 p.研究成果: Article › 同行評審
1 引文 斯高帕斯（Scopus） -
2015
抗癌危害性藥品給藥防護作業指引
張黎露, Chiang, S-C., 邱昌芳, 趙祖怡, 鄧新棠, 謝明欣, 周文珊, 張文, 張淯淵 & 陳侃倫, 1 12月 2015, 於: The Journal of Oncology Nursing. 13, p. 1-54 54 p.研究成果: Article › 同行評審
-
2014
Suboptimal duration of granulocyte colony-stimulating factor use and chemotherapy-induced neutropenia in women diagnosed with breast cancer
Lin, W. T., Wen, Y. W., Chien, C. R., Gau, C. S., Chiang, S. C. & Hsiao, F. Y., 1 9月 2014, 於: Clinical Therapeutics. 36, 9, p. 1287-1294 8 p.研究成果: Article › 同行評審
3 引文 斯高帕斯（Scopus） -
2013
Implementing an evidence-based risk assessment tool to predict chemotherapy-induced neutropenia in women with breast cancer
Chang, L. L., Schneider, S. M., Chiang, S. C. & Horng, C. F., 5月 2013, 於: Cancer Nursing. 36, 3, p. 198-205 8 p.研究成果: Article › 同行評審
2 引文 斯高帕斯（Scopus） -
2012
台灣跨專業共識之化學治療安全作業指引
張黎露, 劉滄梧, 鄧新棠, 邱昌芳, Chiang, S-C., 張美娟 & 張瀞文, 12月 2012, 於: 腫瘤護理雜誌. 12, 2, p. 1-17 17 p.研究成果: Article › 同行評審
-
-
2010
-
2006